Pharma Equity Group Cash Flow Statement

Financials in millions DKK. Fiscal year is January - December.

Millions DKK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-30.81	-24.61	-9.44
Depreciation & Amortization	0.45	0.48	0.54
Stock-Based Compensation	-	-	0.22
Other Operating Activities	1.41	-0.29	-0.37
Change in Accounts Receivable	2.1	-1.36	0.16
Change in Accounts Payable	1.63	2.02	0.86
Change in Other Net Operating Assets	2.27	2.73	-0.26
Operating Cash Flow	-18.55	-16.62	-8.3
Capital Expenditures	-	-0.07	-
Investing Cash Flow	-	-0.07	-
Short-Term Debt Issued	-	5.25	-
Long-Term Debt Issued	-	8	-
Total Debt Issued	27.01	13.25	-
Short-Term Debt Repaid	-	-4.33	-
Long-Term Debt Repaid	-	-0.2	-0.28
Total Debt Repaid	-5.94	-4.53	-0.28
Net Debt Issued (Repaid)	21.07	8.72	-0.28
Issuance of Common Stock	-	12.19	-
Other Financing Activities	-4.66	-3.85	-
Financing Cash Flow	15.9	17.06	-0.28
Miscellaneous Cash Flow Adjustments	-	1.04	-
Net Cash Flow	-2.65	1.4	-8.57
Free Cash Flow	-18.55	-16.7	-8.3
Free Cash Flow Per Share	-0.02	-0.02	-0.01
Cash Interest Paid	2.06	1.43	0.02
Cash Income Tax Paid	-	-1.86	-1.48
Levered Free Cash Flow	-13.74	-64.98	-
Unlevered Free Cash Flow	-11.43	-64	-
Change in Net Working Capital	-6.35	48.6	-

Source: S&P Capital IQ. Standard template. Financial Sources.